Informations techniques
Exploitant
IDORSIA PHARMACEUTICALS FRANCE SAS
Présentation
QUVIVIQ 25 mg, comprimé pelliculé
plaquette(s) PVC PVDC PVC-Aluminium de 30 comprimé(s) (CIP : 34009 302 504 0 2)
QUVIVIQ 50 mg, comprimé pelliculé
plaquette(s) PVC PVDC PVC-Aluminium de 30 comprimé(s) (CIP : 34009 302 504 2 6)
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
xfWp24pdFNnnPksD